Liza Marie Quintana, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cell Biology | 1 | 2021 | 92 | 0.810 |
Why?
|
| Phyllodes Tumor | 3 | 2021 | 54 | 0.610 |
Why?
|
| Breast Neoplasms | 8 | 2022 | 20062 | 0.230 |
Why?
|
| Microscopy, Ultraviolet | 1 | 2018 | 3 | 0.170 |
Why?
|
| Lymph Nodes | 2 | 2020 | 3424 | 0.160 |
Why?
|
| Papilloma | 1 | 2018 | 155 | 0.160 |
Why?
|
| Cartilage | 1 | 2019 | 806 | 0.130 |
Why?
|
| Prostatic Neoplasms | 1 | 2016 | 10605 | 0.120 |
Why?
|
| Nurses | 1 | 2022 | 2376 | 0.120 |
Why?
|
| Lymph Node Excision | 1 | 2019 | 1192 | 0.120 |
Why?
|
| Immunohistochemistry | 3 | 2018 | 11689 | 0.090 |
Why?
|
| Diagnostic Errors | 1 | 2016 | 1267 | 0.080 |
Why?
|
| Mediastinum | 2 | 2020 | 263 | 0.080 |
Why?
|
| Reference Standards | 2 | 2021 | 996 | 0.080 |
Why?
|
| Prostatectomy | 1 | 2016 | 1796 | 0.080 |
Why?
|
| Biomedical Research | 1 | 2020 | 3268 | 0.060 |
Why?
|
| Research Design | 1 | 2020 | 5902 | 0.060 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2018 | 9004 | 0.060 |
Why?
|
| Vitamin D | 1 | 2016 | 3193 | 0.060 |
Why?
|
| Gene Expression Profiling | 1 | 2017 | 9504 | 0.050 |
Why?
|
| Skin Neoplasms | 1 | 2018 | 5318 | 0.040 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2022 | 901 | 0.040 |
Why?
|
| Histological Techniques | 1 | 2018 | 210 | 0.040 |
Why?
|
| Humans | 13 | 2022 | 715818 | 0.040 |
Why?
|
| Retinoid X Receptors | 1 | 2016 | 91 | 0.040 |
Why?
|
| Ultrasonography, Mammary | 1 | 2018 | 252 | 0.040 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2022 | 1162 | 0.040 |
Why?
|
| Lung Neoplasms | 1 | 2020 | 12540 | 0.040 |
Why?
|
| Radioimmunoassay | 1 | 2016 | 956 | 0.040 |
Why?
|
| Needles | 1 | 2018 | 443 | 0.040 |
Why?
|
| Stromal Cells | 1 | 2021 | 1338 | 0.030 |
Why?
|
| Workflow | 1 | 2020 | 821 | 0.030 |
Why?
|
| Endosonography | 1 | 2019 | 573 | 0.030 |
Why?
|
| Retrospective Studies | 3 | 2019 | 72473 | 0.030 |
Why?
|
| Tissue Array Analysis | 1 | 2016 | 573 | 0.030 |
Why?
|
| Mastectomy, Segmental | 1 | 2019 | 949 | 0.030 |
Why?
|
| Receptors, Estrogen | 1 | 2022 | 2167 | 0.030 |
Why?
|
| Predictive Value of Tests | 2 | 2020 | 15198 | 0.030 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2019 | 1059 | 0.030 |
Why?
|
| Receptors, Calcitriol | 1 | 2016 | 351 | 0.030 |
Why?
|
| Fibrosis | 1 | 2020 | 1928 | 0.030 |
Why?
|
| International Cooperation | 1 | 2020 | 1438 | 0.030 |
Why?
|
| Female | 9 | 2022 | 377229 | 0.030 |
Why?
|
| Cooperative Behavior | 1 | 2020 | 1554 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2022 | 2939 | 0.030 |
Why?
|
| Aged | 4 | 2019 | 162468 | 0.030 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2021 | 8896 | 0.030 |
Why?
|
| Middle Aged | 4 | 2019 | 214666 | 0.020 |
Why?
|
| Ultrasonography, Interventional | 1 | 2019 | 1474 | 0.020 |
Why?
|
| Equipment Design | 1 | 2018 | 3587 | 0.020 |
Why?
|
| Biopsy | 1 | 2020 | 6737 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2016 | 4040 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2020 | 7901 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2020 | 13219 | 0.020 |
Why?
|
| Aged, 80 and over | 2 | 2019 | 58326 | 0.010 |
Why?
|
| Young Adult | 2 | 2019 | 56228 | 0.010 |
Why?
|
| Male | 2 | 2019 | 350352 | 0.010 |
Why?
|
| Logistic Models | 1 | 2016 | 13623 | 0.010 |
Why?
|
| Adult | 3 | 2019 | 212279 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2021 | 40032 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2016 | 21795 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2016 | 39305 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2016 | 51317 | 0.010 |
Why?
|
| Risk Factors | 1 | 2016 | 70879 | 0.010 |
Why?
|
| Neoplasms | 1 | 2017 | 20528 | 0.010 |
Why?
|